treatment of breast cancer is based on maximum tolerated dose (MTD) approach. This strategy, however, presents several disadvantages, including prolonged time intervals between treatment cycles and development of…
other liposomal drugs were approved by the FDA and more liposomal drugs are under development. Doxil is based on the combination of high and stable drug loading which is also ... treating cancers, neurodegenerative and…
based nanoparticle with paclitacel (Abraxane®) approved for the treatment of metastatic breast cancer, pancreatic cancer and NSCLC. An alternative to physically adsorbing drugs is to attach the latter covalently…
investigate the role of XPG gene polymorphisms (rs2094258, rs751402, and rs17655) in the development of breast cancer. Patients with breast cancer (320) and control subjects (294) were consecutively selected from…
protein-coupled receptor (LGR) is known to participate in the occurrence and development of breast cancer by regulating the rebirth of tumor vessels. This study aimed to explore the proliferation ... protein-coupled…
incidence and mortality rates of lung cancer in Asia have increased over the past few decades. Owing to the development of molecular-targeted drugs, the prognosis for patients with advanced ... lung cancer for…
cells are bone marrow-derived lymphocytes crucial for host defense against several infections and cancer. We have previously shown that compared to young, aged C57BL/6 mice have decreased numbers ... cell intrinsic. To…
negative cancer cells. Its expression found to be correlated with poor prognosis of various cancers. It is believed that PROM1 maintains the stem cellness of progenitor cells and losses ... PROM1 as early as embryonic…
cardiovascular diseases, diabetes, and certain types of cancer. This study concerned with the use of Broussonetia luzonicus leaves to prevent the development of obesity in male Swiss mice. Broussonetia luzonicus
multidrug resistance-associated proteins (MRP1,MRP2), and breast cancer resistance protein (BCRP). New chemotherapeutic drug delivery systems have been developed to combat drug resistance and multidrug resistance…
Cancer is the leading cause of death in economically developed countries and the second leading cause of death in developing countries. The World Health Organization (WHO) estimates that 84 million ... diminish the drug…
Background: Over the years perception and uptake of cervical cancer screening services has remained poor in developing countries including Ethiopia. Data on barriers of Ethiopian women regarding cervical cancer
cells are bone marrow-derived lymphocytes crucial for host defense against several infections and cancer. We have previously shown that compared to young, aged C57BL/6 mice have decreased numbers ... cell intrinsic. To…
Stem cell-based therapies are emerging as a promising strategy to tackle cancer. Multiple stem cell types have been shown to exhibit inherent tropism towards tumors. Moreover, when engineered ... events in…
Amniotic membrane (AM) develops two different types of pluripotent stem cells which have previously shown to express angiogenesis regulatory properties that make them great candidates for cancer and cardiac researches
cell development mechanism. The failure of the internal cellular clock from this mechanism may play an important role in cancerogenesis. The parameter K may determine cancerization with a probability threshold
Cancer stem cells (CSCs) are considered to be important for tumor development, metastasis, and chemoresistance based on their key ability to survive standard cancer chemotherapies. Multiple studies have now defined
negative cancer cells. Its expression found to be correlated with poor prognosis of various cancers. It is believed that PROM1 maintains the stem cell-ness of progenitor cells and losses ... PROM1 as early as embryonic…
metastatic cancers are often known to be refractory to therapies. Development of an effective therapeutic strategy for metastatic cancer relies on the identification of sensitive molecular targets that are specific…
varying severity adjacent to thyroid tumours is frequently observed. Risk factors for the development of thyroid cancer include radiation exposure, somatic and germline genetic mutations. Common mutations that precede
goiters are frequently noted in developing countries, but are not as frequently treated in developed countries. Management of massive thyroid goiters is frequently referred to tertiary university hospitals…
especially RNA-Seq, has become very useful tools to identify gene alterations in cancer and a powerful approach for investigating the tumorgenesis. While we are still faced with the challenge ... false-negative results…
most notable risk factor for the development of lower urinary tract cancers is occupational exposure to aromatic amines, first noted in England in 1895. Occupational exposure to carcinogenic compounds found
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.